ReviewJournal of molecular medicine (Berlin, Germany)2014

Therapeutic targeting of ERBB2 in breast cancer: understanding resistance in the laboratory and combating it in the clinic.

Alessandra Fabi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.